header-logo header-logo

09 December 2021 / Stephen Gold
Issue: 7960 / Categories: Features
printer mail-detail

Book review: The Law and Regulation of Medicines and Medical Devices, Second Edition

"There is a wealth of information and education on offer. Litigators will join the medics and the researchers in lapping them up"

Author: Peter Feldschreiber

Publisher: Oxford University Press

ISBN: 9780192847546

RRP: £150


Things have moved on since the first century BC when physicians who strayed from the practice rule book which they and their ancestors had written were subjected to trial under penalty of death. Arguably, a multi-track before a QBD judge for allegedly doing what no body of colleagues would have done is only a marginally preferable outcome. And how this work has moved on since its first edition five years ago. I reviewed it then. I confess I did not jump at the opportunity. Its subject matter struck me as no more compelling than the history of local unitary authorities’ drainage systems. Titles can be deceptive. It was a fascinating read and unique in drawing together the threads of medico-pharmaceutical law in one place. And now, like all second editions, bigger and better than what preceded it, with an impressive array

If you are not a subscriber, subscribe now to read this content
If you are already a subscriber sign in
...or Register for two weeks' free access to subscriber content

MOVERS & SHAKERS

Jurit LLP—Caroline Williams

Jurit LLP—Caroline Williams

Private wealth and tax team welcomes cross-border specialist as consultant

Freeths—Michelle Kirkland Elias

Freeths—Michelle Kirkland Elias

International hospitality and leisure specialist joins corporate team as partner

Flint Bishop—Deborah Niven

Flint Bishop—Deborah Niven

Firm appoints head of intellectual property to drive northern growth

NEWS
Talk of a reserved ‘Welsh seat’ on the Supreme Court is misplaced. In NLJ this week, Professor Graham Zellick KC explains that the Constitutional Reform Act treats ‘England and Wales’ as one jurisdiction, with no statutory Welsh slot
The government’s plan to curb jury trials has sparked ‘jury furore’. Writing in NLJ this week, David Locke, partner at Hill Dickinson, says the rationale is ‘grossly inadequate’
A year after the $1.5bn Bybit heist, crypto fraud is booming—but so is recovery. Writing in NLJ this week, Neil Holloway, founder and CEO of M2 Recovery, warns that scams hit at least $14bn in 2025, fuelled by ‘pig butchering’ cons and AI deepfakes
After Woodcock confirmed no general duty to warn, debate turns to the criminal law. Writing in NLJ this week, Charles Davey of The Barrister Group urges revival of misprision or a modern equivalent
Family courts are tightening control of expert evidence. Writing in NLJ this week, Dr Chris Pamplin says there is ‘no automatic right’ to call experts; attendance must be ‘necessary in the interests of justice’ under FPR Pt 25
back-to-top-scroll